Showing results (301-310 of 981) with videos related to
Sort By:
Pageof 99
Cardiovascular Therapeutics|August 27, 2025
The Application Value of Brain Natriuretic Peptide in the Prognostic Evaluation of Patients With Chronic Left Heart FailureCongling Xiang, Weier ZhouCardiovascular Therapeutics|May 20, 2020
Cardioprotective Effect of (Z)-2-Acetoxy-3-(3,4-Dihydroxyphenyl) Acrylic Acid: Inhibition of Apoptosis in CardiomyocytesWei Guo, Zhijun Wang, Hao Jue, et al.Cardiovascular Therapeutics|June 26, 2015
Management of Noncardiac Comorbidities in Chronic Heart FailureVun Heng Chong, Jagdeep Singh, Helen Parry, et al.Cardiovascular Therapeutics|June 3, 2015
Administration of antiarrhythmic drugs to maintain sinus rhythm after catheter ablation for atrial fibrillation: a meta-analysisXiuli Xu, Choumi T Alida, Bo YuCardiovascular Therapeutics|June 3, 2015
The Effect of Testosterone and Fenofibrate, Administered Alone or in Combination, on Cardiometabolic Risk Factors in Men with Late-Onset Hypogonadism and Atherogenic DyslipidemiaRobert Krysiak, Wojciech Gilowski, Bogusław OkopienCardiovascular Therapeutics|August 5, 2016
Secondary preventive medication use in a prevalent population-based cohort of acute coronary syndrome survivorsAnthony S Gunnell, Joseph Hung, Matthew W Knuiman, et al.Cardiovascular Therapeutics|February 27, 2017
Prevalence of in-hospital nonsteroidal antiinflammatory drug exposure in patients with a primary diagnosis of heart failurePaulino A Alvarez, David Putney, Richard Ogunti, et al.Cardiovascular Therapeutics|June 22, 2017
Pharmacokinetics and pharmacodynamics of bococizumab, a monoclonal antibody to PCSK9, after single subcutaneous injection at three sites [NCT 02043301]Ellen Q Wang, Anna Plotka, Joanne Salageanu, et al.Cardiovascular Therapeutics|February 27, 2010
Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trialsHenry Krum, John J V McMurray, Edward Horton, et al.Cardiovascular Therapeutics|September 9, 2016
Onset-to-device time of patients who arrive at off-hours: Importance of prehospital management and public awareness for patients with ST-segment elevation myocardial infarctionYukio Mizuguchi, Hiroki Shibutani, Sho Hashimoto, et al.Pageof 99